Xeris Pharmaceuticals Reports Second Quarter 2020 Financial Results and Corporate Highlights

Go back to Xeris Pharmaceuticals Reports Second Quarter 2020 Financial Results and Corporate Highlights
(NASDAQ: XERS) Delayed: 8.80 +0.60 (7.32%)
Previous Close $8.20    52 Week High
Open $8.28    52 Week Low
Day High $8.81    P/E N/A 
Day Low $8.16    EPS
Volume 3,231,367